Bayer AG (Germany) and Bracco Imaging S.p.A. (Italy) are Leading Players in the Contrast Media Injectors Market
The global contrast media injectors market is projected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029. The market is seeing steady growth driven by rising cancer incidence, increasing number of contras-mediated procedures, and favorable reimbursement scenarios. The upsurge in the geriatric population and technological advancements create a greater demand for this technology.
The contrast media injectors market is consolidated. As of 2023, the key players operating in the global contrast media injectors market are Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Ulrich GmbH & Co. Kg (Germany), and Nemoto Kyorindo (Japan).
To know about the assumptions considered for the study download the pdf brochure
The top players in this market have adopted key strategies such as partnerships, acquisitions, and expansions in the last four years. In 2023, Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), and Guerbet (France) held a major share of the contrast media injectors market.
Bayer AG (Germany)
Bayer Pharma (Pharmaceuticals), a subgroup of Bayer, focuses on the radiology business. Bayer AG operates in more than 100 countries worldwide across North America, Europe, the Asia Pacific, the Middle East & Africa, and Latin America through its subsidiaries. Bayer offers various digital solutions, injection systems, and contrast agents through the radiology business along with the related accessories and consumables being used with contrast media injectors. The company focuses on R&D activities in the pharmaceuticals division on indications with high medical needs. The company has a global presence and operates in more than 100 countries worldwide.
Bracco Imaging S.p.A. (Italy)
Bracco Imaging S.p.A. is a part of the Bracco Group and a global diagnostic imaging leader. The company manufactures and commercializes contrast media injectors and software including contrast agents. To achieve organic growth through innovation and collaborations, Bracco focuses on strategic efforts. The company collaborated with Ulrich GmbH (Germany) to bring Bracco’s MR injector to the US under private label arrangement. Bracco Imaging has manufacturing sites in North America, Europe, Japan, China, Mexico, Brazil, and South Korea with direct or indirect presence in more than 100 countries worldwide. Bracco Imaging has a strong brand value among contrast media injectors end users, strong R&D capabilities, and a robust product portfolio.
Guerbet (France)
Guerbet is another major player operating in the contrast media injectors market. It offers contrast media injectors and related accessories and consumables through its Diagnostic Imaging segment. Guerbet focuses on launching innovative solutions for end users. The company is committed to research & development to create and launch new tools that enhance patient outcomes. In February 2021, Guerbet launched OptiProtect 3S to support imaging centers. It is a technical services and support platform for Guerbet injector. The company operates in Europe, Asia, and the Americas, and distributes its products in about 80 countries.
Related Reports:
Contrast Media Injectors Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), End user (Hospital, Clinic), & Region - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
